Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / U••••• I•••••••••

T••••• Partners to acquire U••••• I•••••••••

Exit to a strategic buyerannouncedannounced Aug 7, 2026Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
industrials / manufactur
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • F••••••••Strategic acquirerconfirmed
    F•••••••• / Pullach (Germany), 7 August 2026 – T••••• Fund 6, advised by T••••• Partners, has signed an agreement to acquire U••••• I•••••••••, a pure play manufacturer of active oxygen solutions, from Funds advised by Equistone Partners Europe.
Sell side
Side not stated
  • F•••••••• / Pullach (Germany), 7 August 2026 – T••••• Fund 6, advised by T••••• Partners, has signed an agreement to acquire U••••• I•••••••••, a pure play manufacturer of active oxygen solutions, from Funds advised by Equistone Partners Europe.
Evidence
F•••••••• / Pullach (Germany), 7 August 2026 – T••••• Fund 6, advised by T••••• Partners, has signed an agreement to acquire U••••• I•••••••••, a pure play manufacturer of active oxygen solutions, from Funds advised by Equistone Partners Europe.
T••••• Partners to acquire U••••• I••••••••• | Private Equity Intelligence | DFX